BeStock  
Stocks › Biotechnology › LKFT

Lakefront Biotherapeutics LKFT

US equityMarket cap rank #2629Biotechnology
$33.31 −$0.08 (-0.24%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $33.31 0.00%
Open$33.61
Prev close$33.39
Day range$33.25 – $33.85
Volume162.5K
Market cap$2.18B
P/E (TTM)2.5
Dividend yield–

Earnings

QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q311 Nov 2026None–-0.21%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By region

  • United States of America€1.08B 97.2%
  • Europe€31.10M 2.8%

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€7.58M-89.4% YoY
Operating profit-€41.17M+1.2% YoY
Net profit-€2.67M+98.7% YoY
Diluted EPS-€0.04+98.7% YoY
Free cash flow-€35.45M+45.8% YoY
Operating cash flow-€35.30M

Revenue, last 8 quarters

€75.5MDec '24€75.0MMar '25€65.3MJun '25€71.2MSep '25€900.8MDec '25€6.5MMar '26€12.1MJun '26€7.6MSep '26

Net profit, last 8 quarters

€25.3MDec '24€-153.4MMar '25€-105.7MJun '25€-202.1MSep '25€782.1MDec '25€14.5MMar '26€2.1MJun '26€-2.7MSep '26

Profitability & balance sheet

Gross margin98.1%
Operating margin65.8%
Net margin85.9%
Return on equity28.0%
Return on assets23.4%
Return on invested capital28.0%
Current ratio46.52
Liabilities / assets1.9%
Cash & investments€2.18B
Total debt€1.83M
Net cash (debt)€2.18B

Discussion

No comments yet — be the first to weigh in on LKFT.

Sign in to join the discussion.

Scroll to Top